AIDSWEEKLY Plus; Monday, July 9, 2007
Staff Medical Writers

HIV is more common among prisoners than among the general population of Thailand—one study, for example, in Klong Prem Central Prison, Bangkok, found that 25% of prisoners who agreed to be tested were HIV positive compared with a general prevalence of 1.5% in the national population. But Thailand’s prisons, say Ford and colleagues, suffer from a lack of health staff and severe budgetary constraints that impede the effective delivery of HIV care and prevention programs.

In June 2003, at the invitation of the prison health services, MSF began providing clinical support in two prisons in Bangkok—Minburi, a remand prison, and Bangkwang, a maximum-security prison. In their PLoS Medicine paper, Ford and colleagues describe running workshops in these prisons on HIV prevention, offering HIV tests to prisoners, and treating prisoners with HIV infection with anti-retroviral and other drug therapies. The authors present data that suggest that the clinical outcomes of patients with HIV treated in these prisons is comparable with treatment programmes in other settings.

"The attitude of the prison health care staff towards the rights of prisoners to access antiretroviral therapy is very positive," say the authors. "The fact that none have questioned that three prisoners facing the death sentence receive antiretroviral treatment is a clear indication of the staff’s commitment to treatment as a basic human right."

Keywords: HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, HIV, Human Immunodeficiency Virus, Virology, Médecins Sans Frontières.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Wilson D, Ford N, Ngammee V, et al., HIV prevention, care, and treatment in two prisons in Thailand, PLoS Med. 2007 Jun;4(6):e204.

PubMED Related articles Search

2007-07-09
AW070704

Copyright © 2007 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.